• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低分子量岩藻聚糖通过调节 P 选择素缓解糖尿病肾病。

Low molecular weight fucoidan modulates P-selectin and alleviates diabetic nephropathy.

机构信息

Key Lab of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China; Laboratory for Marine Biology and Biotechnology, Qingdao National Lab for Marine Science and Technology. Qingdao 266071, China; University of the Chinese Academy of Sciences, Beijing 100049, China.

Key Lab of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China; Laboratory for Marine Biology and Biotechnology, Qingdao National Lab for Marine Science and Technology. Qingdao 266071, China; State Key Lab of Seaweed Bioactive Substances, Qingdao 266000, China.

出版信息

Int J Biol Macromol. 2016 Oct;91:233-40. doi: 10.1016/j.ijbiomac.2016.05.081. Epub 2016 May 24.

DOI:10.1016/j.ijbiomac.2016.05.081
PMID:27234491
Abstract

Diabetic nephropathy (DN) is a serious microvascular complication that can lead to chronic and end-stage renal failure. It is understood that inflammation is associated with the onset and process of DN. Low molecular weight fucoidan (LMWF) isolated from Saccharina japonica has anti-inflammatory properties. Therefore, this study aimed to explore the mechanism of LMWF in DN model induced by streptozotocin. The biochemical indices levels showed LMWF reduced the DN diagnostic indices to protect renal function. The HE stained sections exhibited LMWF protected normal morphological structures and reduced inflammatory cell infiltration in the kidneys of DN rats. Furthermore, the levels of P-selectin and selectin-dependent inflammatory cytokines resulting from LMWF were obviously decreased at both the transcriptional and protein levels. Thus, our results found that LMWF protected the renal function in DN rats and alleviated inflammation through the modulation of P-selectin and inflammatory cytokines. LMWF may have therapeutic potential against DN.

摘要

糖尿病肾病(DN)是一种严重的微血管并发症,可导致慢性和终末期肾衰竭。据了解,炎症与 DN 的发病和进程有关。从裙带菜中分离得到的低分子量褐藻糖胶(LMWF)具有抗炎作用。因此,本研究旨在探讨 LMWF 在链脲佐菌素诱导的 DN 模型中的作用机制。生化指标水平显示,LMWF 降低了 DN 的诊断指标,从而保护了肾功能。HE 染色切片显示,LMWF 保护了 DN 大鼠肾脏的正常形态结构,减少了炎症细胞浸润。此外,LMWF 使 P-选择素和选择素依赖性炎症细胞因子的水平在转录和蛋白水平上明显降低。因此,我们的研究结果发现,LMWF 通过调节 P-选择素和炎症细胞因子来保护 DN 大鼠的肾功能并减轻炎症。LMWF 可能具有治疗 DN 的潜力。

相似文献

1
Low molecular weight fucoidan modulates P-selectin and alleviates diabetic nephropathy.低分子量岩藻聚糖通过调节 P 选择素缓解糖尿病肾病。
Int J Biol Macromol. 2016 Oct;91:233-40. doi: 10.1016/j.ijbiomac.2016.05.081. Epub 2016 May 24.
2
Low molecular weight fucoidan alleviates diabetic nephropathy by binding fibronectin and inhibiting ECM-receptor interaction in human renal mesangial cells.低分子量岩藻聚糖硫酸酯通过与人肾系膜细胞中纤维连接蛋白结合并抑制细胞外基质-受体相互作用来减轻糖尿病肾病。
Int J Biol Macromol. 2020 May 1;150:304-314. doi: 10.1016/j.ijbiomac.2020.02.087. Epub 2020 Feb 11.
3
Low molecular weight fucoidan ameliorates hindlimb ischemic injury in type 2 diabetic rats.低分子量岩藻聚糖硫酸酯可改善 2 型糖尿病大鼠的后肢缺血损伤。
J Ethnopharmacol. 2018 Jan 10;210:434-442. doi: 10.1016/j.jep.2017.09.014. Epub 2017 Sep 14.
4
Low molecular weight fucoidan ameliorates streptozotocin-induced hyper-responsiveness of aortic smooth muscles in type 1 diabetes rats.低分子量岩藻依聚糖改善1型糖尿病大鼠中链脲佐菌素诱导的主动脉平滑肌高反应性。
J Ethnopharmacol. 2016 Sep 15;191:341-349. doi: 10.1016/j.jep.2016.06.054. Epub 2016 Jun 21.
5
Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.沙利度胺通过抗炎途径对链脲佐菌素诱导的糖尿病大鼠的肾脏保护作用。
Drug Des Devel Ther. 2018 Jan 9;12:89-98. doi: 10.2147/DDDT.S149298. eCollection 2018.
6
Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.糖肾方对大鼠糖尿病肾病的治疗作用
PLoS One. 2016 Jan 25;11(1):e0147693. doi: 10.1371/journal.pone.0147693. eCollection 2016.
7
Fucoidan mitigated diabetic nephropathy through the downregulation of PKC and modulation of NF-κB signaling pathway: in vitro and in vivo investigations.岩藻聚糖硫酸酯通过下调 PKC 及调控 NF-κB 信号通路减轻糖尿病肾病:体外和体内研究。
Phytother Res. 2021 Apr;35(4):2133-2144. doi: 10.1002/ptr.6966. Epub 2020 Dec 2.
8
Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.与α-硫辛酸相比,黄葵胶囊通过调节氧化应激和p38丝裂原活化蛋白激酶/蛋白激酶B(p38MAPK/Akt)信号通路减轻糖尿病肾病大鼠的肾纤维化。
J Ethnopharmacol. 2015 Sep 15;173:256-65. doi: 10.1016/j.jep.2015.07.036. Epub 2015 Jul 28.
9
Minocycline Attenuates Kidney Injury in a Rat Model of Streptozotocin-Induced Diabetic Nephropathy.米诺环素减轻链脲佐菌素诱导的糖尿病肾病大鼠模型中的肾损伤。
Biol Pharm Bull. 2016;39(8):1231-7. doi: 10.1248/bpb.b15-00594.
10
Mulberry leaf polysaccharides suppress renal fibrosis.桑叶多糖抑制肾纤维化。
Int J Biol Macromol. 2019 Mar 1;124:1090-1093. doi: 10.1016/j.ijbiomac.2018.12.029. Epub 2018 Dec 3.

引用本文的文献

1
Fermented seaweed extracts ameliorate diabetic nephropathy in streptozotocin-induced diabetic rats via PI3K/AKT/mTOR pathway.发酵海藻提取物通过PI3K/AKT/mTOR通路改善链脲佐菌素诱导的糖尿病大鼠的糖尿病肾病。
Sci Rep. 2025 Jul 2;15(1):22534. doi: 10.1038/s41598-025-06935-5.
2
Potential Application of Marine Fucosyl-Polysaccharides in Regulating Blood Glucose and Hyperglycemic Complications.海洋岩藻糖基多糖在调节血糖及高血糖并发症方面的潜在应用
Foods. 2023 Jul 5;12(13):2600. doi: 10.3390/foods12132600.
3
Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy.
鉴定一种新型免疫图谱特征作为与糖尿病肾病免疫细胞浸润相关的有效诊断标志物。
Front Immunol. 2023 Mar 8;14:1113212. doi: 10.3389/fimmu.2023.1113212. eCollection 2023.
4
Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism.低分子量岩藻聚糖硫酸酯通过调节肾脏脂代谢抑制糖尿病肾脏纤维化。
J Diabetes Res. 2021 Nov 24;2021:7618166. doi: 10.1155/2021/7618166. eCollection 2021.
5
Fucoidan for cardiovascular application and the factors mediating its activities.褐藻糖胶在心血管应用中的作用及其介导活性的因素。
Carbohydr Polym. 2021 Oct 15;270:118347. doi: 10.1016/j.carbpol.2021.118347. Epub 2021 Jun 18.
6
Current Research Landscape of Marine-Derived Anti-Atherosclerotic Substances.海洋来源抗动脉粥样硬化物质的研究现状。
Mar Drugs. 2020 Aug 25;18(9):440. doi: 10.3390/md18090440.
7
Genome-wide analysis of the Saccharina japonica sulfotransferase genes and their transcriptional profiles during whole developmental periods and under abiotic stresses.对日本裙带菜硫转移酶基因的全基因组分析及其在整个发育阶段和非生物胁迫下的转录谱。
BMC Plant Biol. 2020 Jun 11;20(1):271. doi: 10.1186/s12870-020-02422-3.
8
Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology.岩藻依聚糖通过抑制Toll样受体4信号通路、调节树突状细胞/调节性T细胞诱导的免疫耐受以及改善肠道微生态来预防小鼠自身免疫性糖尿病。
Nutr Metab (Lond). 2019 Dec 16;16:87. doi: 10.1186/s12986-019-0392-1. eCollection 2019.
9
Algal Polysaccharides as Therapeutic Agents for Atherosclerosis.藻类多糖作为动脉粥样硬化的治疗药物
Front Cardiovasc Med. 2018 Oct 26;5:153. doi: 10.3389/fcvm.2018.00153. eCollection 2018.
10
Low molecular weight fucoidan attenuates experimental abdominal aortic aneurysm through interfering the leukocyte-endothelial cells interaction.低分子量岩藻聚糖硫酸酯通过干扰白细胞-内皮细胞相互作用来减轻实验性腹主动脉瘤。
Mol Med Rep. 2018 May;17(5):7089-7096. doi: 10.3892/mmr.2018.8765. Epub 2018 Mar 16.